Davis's Drug Guide
teplizumab
General
Pronunciation:
tep-liz-ue-mab
Trade Name(s)
- Tzield
Ther. Class.
Pharm. Class.
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Teplizumab." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580097/2/teplizumab.
Vallerand AHA, Sanoski CAC. Teplizumab. Davis's Drug Guide. F.A. Davis Company; 2026. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580097/2/teplizumab. Accessed June 25, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Teplizumab. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580097/2/teplizumab
Vallerand AHA, Sanoski CAC. Teplizumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 25]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580097/2/teplizumab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - teplizumab
ID - 3580097
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580097/2/teplizumab
PB - F.A. Davis Company
ET - 20
DB - Emergency Central
DP - Unbound Medicine
ER -
